PNC Financial Services Group’s Theratechnologies THTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,000
Closed -$23.6K 5234
2025
Q2
$23.6K Hold
10,000
﹤0.01% 3493
2025
Q1
$14K Hold
10,000
﹤0.01% 3696
2024
Q4
$18.1K Hold
10,000
﹤0.01% 3574
2024
Q3
$12.4K Hold
10,000
﹤0.01% 3720
2024
Q2
$14K Hold
10,000
﹤0.01% 3638
2024
Q1
$16.6K Sell
10,000
-11,742
-54% -$18.8K ﹤0.01% 3541
2023
Q4
$35.2K Hold
21,742
﹤0.01% 3140
2023
Q3
$46.7K Buy
+21,742
New +$46.5K ﹤0.01% 2994

Other funds holding THTX

PNC Financial Services Group's THTX Position: Q3 2025 in Review

PNC Financial Services Group sold out of Theratechnologies (THTX) in Q3 2025, closing a stake of 10,000 shares — an estimated $23.6K sold.

PNC Financial Services Group first reported a position in THTX in Q3 2023 and held it in 8 quarters. The position peaked at $46.7K in Q3 2023. 10 funds tracked by Wall St. Rank hold THTX as of Q3 2025.

  • PNC Financial Services Group reported no remaining Theratechnologies position as of Q3 2025 after selling out during the quarter.
  • PNC Financial Services Group sold 10,000 Theratechnologies shares in Q3 2025, an estimated $23.6K.
  • PNC Financial Services Group first reported a position in Theratechnologies in Q3 2023 and held it in 8 quarters.
  • PNC Financial Services Group's Theratechnologies position peaked at $46.7K in Q3 2023.
  • 10 funds tracked by Wall St. Rank held Theratechnologies as of Q3 2025.

Based on PNC Financial Services Group's 13F filing for Q3 2025, filed 7 Nov 2025.